Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cadranel

Showing results (581-590 of 709) with videos related to

Pageof 71
Sort By:
EMBO Molecular Medicine|December 23, 2016
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanismOlivier Calvayrac, Julien Mazières, Sarah Figarol, et al.
The European Respiratory Journal|May 30, 2015
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosisCaroline Kannengiesser, Raphael Borie, Christelle Ménard, et al.
Critical Care (London, England)|May 20, 2020
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter studyAdrien Mirouse, Antoine Parrot, Vincent Audigier, et al.
Thrombosis and Haemostasis|September 22, 2020
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19Grigoris T Gerotziafas, Theodoros N Sergentanis, Guillaume Voiriot, et al.
Lung Cancer (Amsterdam, Netherlands)|October 11, 2019
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French studyCamille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, et al.
The Oncologist|December 26, 2024
COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancerCamille Mehlman, Aurelie Swalduz, Isabelle Monnet, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
Cystic dystrophy of the duodenal wall associated with chronic alcoholic pancreatitis. Clinical features, diagnostic procedures and therapeutic management in a retrospective multicenter series of 23 patientsVincent Jouannaud, Pierre Coutarel, Hervé Tossou, et al.
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLCMarius Ilié, Julien Mazières, Emmanuel Chamorey, et al.
Acta Gastro-Enterologica Belgica|October 31, 1998
The 1998 national Belgian consensus meeting on HP-related diseases: an extensive summary. The HP Belgian contact group organized in CHU Brugmann, BrusselsM Deltenre, K Geboes, N Ectors, et al.
Pageof 71

Showing results (581-590 of 709) with videos related to

Sort By:
Pageof 71
EMBO Molecular Medicine|December 23, 2016
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanismOlivier Calvayrac, Julien Mazières, Sarah Figarol, et al.
The European Respiratory Journal|May 30, 2015
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosisCaroline Kannengiesser, Raphael Borie, Christelle Ménard, et al.
Critical Care (London, England)|May 20, 2020
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter studyAdrien Mirouse, Antoine Parrot, Vincent Audigier, et al.
Thrombosis and Haemostasis|September 22, 2020
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19Grigoris T Gerotziafas, Theodoros N Sergentanis, Guillaume Voiriot, et al.
Lung Cancer (Amsterdam, Netherlands)|October 11, 2019
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French studyCamille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, et al.
The Oncologist|December 26, 2024
COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancerCamille Mehlman, Aurelie Swalduz, Isabelle Monnet, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
Cystic dystrophy of the duodenal wall associated with chronic alcoholic pancreatitis. Clinical features, diagnostic procedures and therapeutic management in a retrospective multicenter series of 23 patientsVincent Jouannaud, Pierre Coutarel, Hervé Tossou, et al.
Respiratory Research|April 27, 2018
Rituximab for auto-immune alveolar proteinosis, a real life cohort studyBerenice Soyez, Raphael Borie, Cedric Menard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLCMarius Ilié, Julien Mazières, Emmanuel Chamorey, et al.
Acta Gastro-Enterologica Belgica|October 31, 1998
The 1998 national Belgian consensus meeting on HP-related diseases: an extensive summary. The HP Belgian contact group organized in CHU Brugmann, BrusselsM Deltenre, K Geboes, N Ectors, et al.
Pageof 71